SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000939798-17-000104
Filing Date
2017-12-04
Accepted
2017-12-01 19:29:24
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G MARK J SILVERMAN silvermanthirteeng.htm SC 13G 43559
  Complete submission text file 0000939798-17-000104.txt   45099
Mailing Address 1825 K STREET SUITE 510 WASHINGTON, D.C. DC 33602
Business Address 1825 K STREET SUITE 510 WASHINGTON, D.C. DC 33602 (800) 304-9888
GT Biopharma, Inc. (Subject) CIK: 0000109657 (see all company filings)

IRS No.: 941620407 | State of Incorp.: FL | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-32837 | Film No.: 171235278
SIC: 2834 Pharmaceutical Preparations

Mailing Address 224 22ND ST. SANTA MONICA CA 90402
Business Address
Silverman Mark J (Filed by) CIK: 0001721628 (see all company filings)

Type: SC 13G